These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31803957)

  • 1. Genetic liability to ADHD and substance use disorders in individuals with ADHD.
    Wimberley T; Agerbo E; Horsdal HT; Ottosen C; Brikell I; Als TD; Demontis D; Børglum AD; Nordentoft M; Mors O; Werge T; Hougaard D; Bybjerg-Grauholm J; Hansen MB; Mortensen PB; Thapar A; Riglin L; Langley K; Dalsgaard S
    Addiction; 2020 Jul; 115(7):1368-1377. PubMed ID: 31803957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
    Ottosen C; Petersen L; Larsen JT; Dalsgaard S
    J Am Acad Child Adolesc Psychiatry; 2016 Mar; 55(3):227-34.e4. PubMed ID: 26903256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic overlap and causality between substance use disorder and attention-deficit and hyperactivity disorder.
    Vilar-Ribó L; Sánchez-Mora C; Rovira P; Richarte V; Corrales M; Fadeuilhe C; Arribas L; Casas M; Ramos-Quiroga JA; Ribasés M; Soler Artigas M
    Am J Med Genet B Neuropsychiatr Genet; 2021 Apr; 186(3):140-150. PubMed ID: 33244849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention-deficit/hyperactivity disorder and risk for substance use disorders in relatives.
    Skoglund C; Chen Q; Franck J; Lichtenstein P; Larsson H
    Biol Psychiatry; 2015 May; 77(10):880-6. PubMed ID: 25457227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Genetic Risk Variants With Attention-Deficit/Hyperactivity Disorder Trajectories in the General Population.
    Riglin L; Collishaw S; Thapar AK; Dalsgaard S; Langley K; Smith GD; Stergiakouli E; Maughan B; O'Donovan MC; Thapar A
    JAMA Psychiatry; 2016 Dec; 73(12):1285-1292. PubMed ID: 27806167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
    Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
    Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention deficit hyperactivity and oppositional defiant disorder symptoms in adolescence and risk of substance use disorders-A general population-based birth cohort study.
    Mustonen A; Rodriguez A; Scott JG; Vuori M; Hurtig T; Halt AH; Miettunen J; Alakokkare AE; Niemelä S
    Acta Psychiatr Scand; 2023 Sep; 148(3):277-287. PubMed ID: 37431766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men.
    Estévez N; Dey M; Eich-Höchli D; Foster S; Gmel G; Mohler-Kuo M
    Epidemiol Psychiatr Sci; 2016 Jun; 25(3):255-66. PubMed ID: 25989844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
    Steinhausen HC; Bisgaard C
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):232-41. PubMed ID: 24314850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polygenic risk score, psychosocial environment and the risk of attention-deficit/hyperactivity disorder.
    Østergaard SD; Trabjerg BB; Als TD; Climent CA; Privé F; Vilhjálmsson BJ; Bækvad-Hansen M; Bybjerg-Grauholm J; Hougaard DM; Nordentoft M; Werge T; Demontis D; Mortensen PB; Børglum AD; Mors O; Agerbo E
    Transl Psychiatry; 2020 Oct; 10(1):335. PubMed ID: 33009369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disentangling heterogeneity in substance use disorder: Insights from genome-wide polygenic scores.
    Vilar-Ribó L; Cabana-Domínguez J; Alemany S; Llonga N; Arribas L; Grau-López L; Daigre C; Cormand B; Fernàndez-Castillo N; Ramos-Quiroga JA; Soler Artigas M; Ribasés M
    Transl Psychiatry; 2024 May; 14(1):221. PubMed ID: 38811559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults.
    Young JT; Carruthers S; Kaye S; Allsop S; Gilsenan J; Degenhardt L; van de Glind G; van den Brink W; Preen D
    Drug Alcohol Rev; 2015 Nov; 34(6):683-93. PubMed ID: 25790353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex Differences in Comorbidity Patterns of Attention-Deficit/Hyperactivity Disorder.
    Ottosen C; Larsen JT; Faraone SV; Chen Q; Hartman C; Larsson H; Petersen L; Dalsgaard S
    J Am Acad Child Adolesc Psychiatry; 2019 Apr; 58(4):412-422.e3. PubMed ID: 30768399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.
    van Emmerik-van Oortmerssen K; van de Glind G; Koeter MW; Allsop S; Auriacombe M; Barta C; Bu ET; Burren Y; Carpentier PJ; Carruthers S; Casas M; Demetrovics Z; Dom G; Faraone SV; Fatseas M; Franck J; Johnson B; Kapitány-Fövény M; Kaye S; Konstenius M; Levin FR; Moggi F; Møller M; Ramos-Quiroga JA; Schillinger A; Skutle A; Verspreet S; ; van den Brink W; Schoevers RA
    Addiction; 2014 Feb; 109(2):262-72. PubMed ID: 24118292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
    Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
    Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study.
    Brynte C; Aeschlimann M; Barta C; Begeman AHA; Bäcker A; Crunelle CL; Daigre C; De Fuentes-Merillas L; Demetrovics Z; Dom G; López LG; Icick R; Johnson B; Joostens P; Kapitány-Fövény M; Karsinti E; Kiefer F; Konstenius M; Levin FR; Luderer M; Markus W; Matthys F; Moggi F; Palma-Alvarez RF; Paraskevopoulou M; Ramos-Quiroga JA; Schellekens A; Soravia LM; Therribout N; Thomas A; van de Glind G; van Kernebeek MW; Vollstädt-Klein S; Vorspan F; van den Brink W; Franck J
    BMC Psychiatry; 2022 Sep; 22(1):625. PubMed ID: 36151539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is attention-deficit/hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study.
    Szobot CM; Rohde LA; Bukstein O; Molina BS; Martins C; Ruaro P; Pechansky F
    Addiction; 2007 Jul; 102(7):1122-30. PubMed ID: 17567400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse.
    Elkins IJ; McGue M; Iacono WG
    Arch Gen Psychiatry; 2007 Oct; 64(10):1145-52. PubMed ID: 17909126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay of ADHD Polygenic Liability With Birth-Related, Somatic, and Psychosocial Factors in ADHD: A Nationwide Study.
    Brikell I; Wimberley T; Albiñana C; Vilhjálmsson BJ; Agerbo E; Børglum AD; Demontis D; Schork AJ; LaBianca S; Werge T; Hougaard DM; Nordentoft M; Mors O; Mortensen PB; Petersen LV; Dalsgaard S
    Am J Psychiatry; 2023 Jan; 180(1):73-88. PubMed ID: 36069019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues.
    Wilens TE
    Psychiatr Clin North Am; 2004 Jun; 27(2):283-301. PubMed ID: 15063998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.